High-performance liquid chromatographic method for the determination of labetalol in plasma using ultraviolet detection
- 31 December 1984
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 305 (1), 222-227
- https://doi.org/10.1016/s0378-4347(00)83334-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detectionJournal of Pharmacological Methods, 1981
- Sensitive high-performance liquid chromatographic method for the determination of labetalol in human plasma using fluorimetric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Determination of labetalol in human plasma by high-performance liquid chromatographyJournal of Chromatography A, 1979
- Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.British Journal of Clinical Pharmacology, 1979
- Labetalol: Bioavailability, Drug Plasma Levels, Plasma Renin and Catecholamines in Acute and Chronic Treatment of Resistant HypertensionAustralian and New Zealand Journal of Medicine, 1978
- Relationship between plasma concentrations and pharmacological effects of labetalolEuropean Journal of Clinical Pharmacology, 1977
- Assessment of alpha‐ and beta‐adrenoceptor blocking actions of labetalol.British Journal of Clinical Pharmacology, 1976
- INTRAVENOUS LABETALOL IN SEVERE HYPERTENSIONThe Lancet, 1975
- Pharmacology of AH 5158; a drug which blocks both α‐ and β‐adrenoceptorsBritish Journal of Pharmacology, 1972
- Preliminary Studies of the Pharmacological Effects of 5-{1-Hydroxy-2-[(1-Methyl-3-Phenylpropyl) Amino]-Ethyl}Salicylamide (AH 5158) in ManClinical Science, 1971